News
Tartu University Hospital Expanding Clinical Trial Capabilities Internationally with TriNetX
Tallinn, ESTONIA, 4 June, 2018 — Tartu University Hospital, the only university hospital in Estonia and an e-Health pioneer, has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally. TriNetX’s rapidly...
TriNetX Unveils State-of-the-Art Analytics Solutions for Use with Its Clinical Data
Enables Researchers to Hypothesize and Answer Complex Research Questions About Patient Outcomes & Treatment Effectiveness BALTIMORE, MD – ISPOR 2018 – May 21, 2018 – TriNetX™, the global health research network, today announced the availability of TriNetX...
ISPOR 2018 – “Using Real World Data to Establish an Optimal Treatment Target for Hba1c in Diabetes Type 2”
Presented at ISPOR 2018, this poster investigates using real world data to establish an optimal treatment target for Hba1c in diabetes type 2. Stapff MP, Palm S, Stacey J TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster >>
ISPOR 2018 – “A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients”
Presented at ISPOR 2018, this poster is a real-world data analysis evaluating the time to glycemic control after initiation of basal insulin in type 2 diabetic patients. Stacey J, Hilderbrand S, Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...
ISPOR 2018 – “Comparison of Bleeding Events, Strokes, and Myocardial Infarcts on Warfarin or Dabigatran for Treatment of Atrial Fibrillation: Results of a Real-World Data Analysis”
Presented at ISPOR 2018, this poster is a comparison of bleeding events, strokes, and myocardial infarcts on warfarin or dabigatran for treatment of atrial fibrillation: results of a real-world data analysis. Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018...